Can a simple blood test predict if cancer treatment is working?
NCT ID NCT05487248
Summary
This study aims to learn if tracking cancer DNA in the blood can predict how well standard chemotherapy works for people with advanced colorectal cancer that has stopped responding to prior treatments. It observes 103 patients receiving their doctor's chosen standard therapy, collecting blood samples regularly to see if changes in cancer DNA match up with scan results. The goal is to gather knowledge that could help guide future treatment decisions, but it does not test a new treatment itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHIREC Delta
Brussels, Belgium
-
CHU Ambroise Pare
Mons, 7000, Belgium
-
CHU Poitiers
Poitiers, France
-
Centre Georges François Leclerc
Dijon, France
-
Cliniques Universitaires Saint Luc
Woluwe-Saint-Lambert, 1200, Belgium
-
Hopital Franco-Britannique - Fondation Cognacq-Jay
Levallois-Perret, 92300, France
-
Hopital St-Louis
Paris, France
-
Hopital privé Jean Mermoz
Lyon, France
-
ICANS Strasbourg
Strasbourg, France
-
ICO Saint-Herblain
Saint-Herblain, France
-
Institut Jules Bordet
Anderlecht, 1070, Belgium
-
UZ Antwerpen
Antwerp, Belgium
Conditions
Explore the condition pages connected to this study.